1
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Total mutation burden (TMB) in lung cancer (LC) and relationship with response to PD-1/PD-L1 targeted therapies.

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Author and article information

          Journal
          Journal of Clinical Oncology
          JCO
          American Society of Clinical Oncology (ASCO)
          0732-183X
          1527-7755
          May 20 2016
          May 20 2016
          : 34
          : 15_suppl
          : 9017
          Affiliations
          [1 ]Sarah Cannon Research Institute, Nashville, TN;
          [2 ]Foundation Medicine, Inc., Cambridge, MA;
          [3 ]Foundation Medicine, Boston, MA;
          [4 ]Sarah Cannon Research Institute, and Tennessee Oncology, PLLC., Nashville, TN;
          [5 ]University of Michigan, Ann Arbor, MI;
          [6 ]Memor Cancer Inst, Pembroke Pines, FL;
          [7 ]Chao Family Comprehensive Cancer Center, University of California Irvine, Orange County, CA;
          [8 ]Albany Medical College, Albany, NY;
          Article
          10.1200/JCO.2016.34.15_suppl.9017
          e0c69395-185e-4762-928f-6ac4796c0b83
          © 2016
          History

          Comments

          Comment on this article